Intron 4 a/b polymorphism of the endothelial nitric oxide synthase gene is associated with both type 1 and type 2 diabetes in a genetically homogeneous population

Human Immunology

Volumn 69, Issue 4-5, 2008, Pages 279-283

  Galanakis, Emmanouil ^a   Kofteridis, Diamantis ^a   Stratigi, Kalliopi ^a   Petraki, Eleni ^a   Vazgiourakis, Vassilios ^a   Fragouli, Eleni ^a   Mamoulakis, Dimitrios ^a   Boumpas, Dimitrios T ^a,b   Goulielmos, George N ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Endothelial nitric oxide synthase gene; Gene polymorphisms; Genetic background; Type 1 diabetes; Type 2 diabetes

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HOMOZYGOSITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRON; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; WILD TYPE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREECE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; ODDS RATIO; POLYMORPHISM, GENETIC; TANDEM REPEAT SEQUENCES;

EID: 43449095982     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.03.001     Document Type: Article

References (49)

1. Donath M.Y., and Ehses J.A. Type 1, type 1.5, and type 2 diabetes. NOD the diabetes we thought it was. Proc Natl Acad Sci USA 103 (2006) 12217
2. Nejentsev S., Howson J.M., Walker N.M., Szeszko J., Field S.F., Stevens H.E., et al. Wellcome Trust Case Control Consortium. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450 (2007) 887
3. Welcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661
4. Pociot F., and McDermott M.F. Genetics of type 1 diabetes mellitus. Genes Immun 3 (2002) 235
5. Haller K., Kisand K., Nemvalts V., Laine A.P., Ilonen J., and Uibo R. Type 1 diabetes is insulin -2221 MspI and CTLA-4 +49 A/G polymorphism dependent. Eur J Clin Invest 34 (2004) 543
6. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36 (2004) 337
7. Bailey R., Cooper J.D., Zeitels L., Smyth D.J., Yang J.H., Walker N.M., et al. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 56 (2007) 2616
8. Hakonarson H., Grant S.F.A., Bradfield J.P., Marchand L., Kim C.E., Glessner J.T., et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 448 (2007) 591
9. Smyth D.J., Cooper J.D., Bailey R., Field S., Burren O., Smink L.J., et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 38 (2006) 617
10. Lowe C.E., Cooper J.D., Brusko T., Walker N.M., Smyth D.J., Bailey R., et al. A.large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet 39 (2007) 1074
11. Elbein S.C., Chu W., Ren Q., Hemphill C., Schay J., Cox N.J., et al. Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians. J Clin Endocrinol Metab 87 (2002) 650
12. Myles S., Hradetzky E., Engelken J., Lao O., Nürnberg P., Trent R.J., et al. Identification of a candidate genetic variant for the high prevalence of type II diabetes in Polynesians. Eur J Hum Genet 15 (2007) 584
13. Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38 (2006) 320
14. Saxena R., Gianniny L., Burtt N.P., Lyssenko V., Giuducci C., Sjögren M., et al. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55 (2006) 2890
15. van Tilburg J.H., Sandkuijl L.A., Strengman E., van Someren H., Rigters-Aris C.A., Pearson P.L., et al. A genome-wide scan in type 2 diabetes mellitus provides independent replication of a susceptibility locus on 18p11 and suggests the existence of novel loci on 2q12 and 19q13. J Clin Endocrinol Metab 88 (2003) 2223
16. Hoffmann K., Mattheisen M., Dahm S., Nürnberg P., Roe C., Johnson J., et al. A German genome-wide linkage scan for type 2 diabetes supports the existence of a metabolic syndrome locus on chromosome 1p36.13 and a type 2 diabetes locus on chromosome 16p12.2. Diabetologia 50 (2007) 1418
17. Macdonald M.J., Gottischall J., Hunter J.B., Winter K.L., Johnson S.D., Blank J.L., et al. In insulin-dependent diabetes, the expression of an HLA-DR4-related susceptibility gene is dominant, but expression of a DR3-Related gene is dependent on the DR4-related gene. Ann N Y Acad Sci 475 (1986) 356
18. Payne F., Cooper J.D., Walker N.M., Lam A.C., Smink L.J., Nutland S., et al. Interaction analysis of the CBLB and CTLA4 genes in type 1 diabetes. J Leukocyte Biol 81 (2007) 581
19. Sharma A., Chavali S., Mahajan A., Tabassum R., Banerjee V., Tandon N., and Bharadwaj D. Genetic association, post-translational modification, and protein-protein interactions in type 2 diabetes mellitus. Mol Cell Proteomics 4 (2005) 1029
20. Gross S.S., and Wolin M.S. Nitric oxide: Pathophysiological mechanisms. Annu Rev Physiol 57 (1995) 737
21. Marsden P.A., Heng H.H., Scherer S.W., Stewart R.J., Hall A.V., Shi X.M., et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268 (1993) 17478
22. Albrecht E.D., Aberdeen G.W., Niklaus A.L., Babischkin J.S., Suresch D.L., and Pepe G.J. Acute temporal regulation of vascular endothelial growth/permeability factor expression and endothelial morphology in the baboon endometrium by ovarian steroids. J Clin Endocrinol Metab 88 (2003) 2844
23. Bucala R., Ritchlin C., Winchester R., and Cerami A. Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med 173 (1991) 569
24. Pieper G.M. Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: Importance of disease duration. Diabetologia 42 (1999) 204
25. Colasanti M., and Suzuki H. The dual personality of NO. Trends Pharmacol Sci 21 (2000) 249
26. Wang X.L., and Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metabol 70 (2000) 241
27. Tsukada T., Yokoyama K., Arai T., Takemoto F., Hara S., Yamada A., et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 245 (1998) 190
28. Lee Y.H., Kim H.J., Rho Y.H., Choi S.J., Ji J.D., and Song G.G. Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with the development of lupus nephritis. Lupus 13 (2004) 188
29. Park H.W., Lee J.E., Shin E.S., Lee J.Y., Bahn J.W., Oh H.B., et al. Association between genetic variations of vascular endothelial growth factor receptor 2 and atopy in the Korean population. J Allergy Clin Immunol 117 (2006) 774
30. Peltonen L., Jalanko A., and Varilo T. Molecular genetics of the Finnish disease heritage. Hum Mol Genet 8 (1999) 1913
31. Mamoulakis D., Galanakis E., Bicouvarakis S., Paraskakis E., and Sbyrakis S. Epidemiology of childhood type I diabetes in Crete 1990-2001. Acta Paediatr 92 (2003) 737
32. Miyahara K., Kawamoto T., Sase K., Yui Y., Toda K., Yang L.X., et al. Cloning and structural characterization of the human endothelial nitric oxide synthase gene. Eur J Biochem 223 (1994) 719
33. Noiri E., Satoh H., Taguchi J., Brodsky S.V., Nakao A., Ogawa Y., et al. Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 40 (2002) 535
34. Song J., Yoon Y., Park K.U., Park J., Hong Y.J., Hong S.H., and Kim J.Q. Genotype-specific influence on nitric oxide synthase gene expression, protein concentrations, and enzyme activity in cultured human endothelial cells. Clin Chem 49 (2003) 847
35. Wang J., Dudley D., and Wang X.L. Haplotype-specific effects on endothelial NO synthase promoter efficiency: Modifiable by cigarette smoking. Arterioscler Thromb Vasc Biol 22 (2002) 1
36. Fatini C., Sofi F., Sticchi E., Gensini F., Gori A.M., Fedi S., et al. Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am Heart J 147 (2004) 516
37. Li H., and Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J Pathol 190 (2000) 244
38. Kutlu B., Cardozo A.K., Darville M.I., Kruhoffer M., Magnusson N., Orntoft T., et al. Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes 52 (2003) 2701
39. Chan N.N., and Chan J.C. Asymmetric dimethylarginine (ADMA): A potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?. Diabetologia 45 (2002) 1609
40. Gryglewski R.J., Palmer R.M., and Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320 (1986) 454
41. Ding Y., Vaziri N.D., Coulson R., Kamanna V.S., and Roh D.D. Effect of simulated hyperglycemia, insulin, and glucagons on endothelial nitric oxide synthase expression. Am J Physiol Endocrinol Metab 279 (2000) E11
42. Hibi K., Ishigami T., Tamura K., Mizushima S., Nyui N., Fujita T., et al. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 32 (1998) 521
43. Baron A.D., Zhu J.S., Marshall S., Irsula O., Brechtel G., and Keech C. Insulin resistance after hypertension induced by the nitric oxide synthesis inhibitor L-NMMA in rats. Am J Physiol 269 (1995) E709
44. Rhodes C.J. Type 2 diabetes-a matter of beta-cell life and death?. Science 307 (2005) 380
45. Monti L.D., Barlassina C., Citterio L., Galluccio E., Berzuini C., Setola E., et al. Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes 52 (2003) 1270
46. Zanelli E., Breedveld F.C., and de Vries R.R. HLA association with autoimmune disease: A failure to protect?. Rheumatology 10 (2000) 1060
47. Kone B.C., and Baylis C. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol 272 (1997) F561
48. Haynes W.G., Hand M.F., Dockrell M.E., Eadington D.W., Lee M.R., Hussein Z., et al. Physiological role of nitric oxide in regulation of renal function in humans. Am J Physiol 272 (1997) F364
49. Trachtman H., Futterweit S., Pine E., Mann J., and Valderrama E. Chronic diabetic nephropathy: Role of inducible nitric oxide synthase. Pediatr Nephrol 17 (2000) 20